TCGA had previously predicted XBP1 to be an important part of a regulatory signalling hub in endometrial cancer [104] and subsequently demonstrated that XBP1 was enriched in endometrial tumours versus breast tumours [105]. The gene discussed is XBP1; the disease is endometrial cancer.